These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

349 related articles for article (PubMed ID: 30714719)

  • 1. Alpha-Synuclein in Peripheral Tissues in Parkinson's Disease.
    Ma LY; Liu GL; Wang DX; Zhang MM; Kou WY; Feng T
    ACS Chem Neurosci; 2019 Feb; 10(2):812-823. PubMed ID: 30714719
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Can we use peripheral tissue biopsies to diagnose Parkinson's disease? A review of the literature.
    Schneider SA; Boettner M; Alexoudi A; Zorenkov D; Deuschl G; Wedel T
    Eur J Neurol; 2016 Feb; 23(2):247-61. PubMed ID: 26100920
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Dermal phospho-alpha-synuclein deposits confirm REM sleep behaviour disorder as prodromal Parkinson's disease.
    Doppler K; Jentschke HM; Schulmeyer L; Vadasz D; Janzen A; Luster M; Höffken H; Mayer G; Brumberg J; Booij J; Musacchio T; Klebe S; Sittig-Wiegand E; Volkmann J; Sommer C; Oertel WH
    Acta Neuropathol; 2017 Apr; 133(4):535-545. PubMed ID: 28180961
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Alpha-synuclein seeds in olfactory mucosa of patients with isolated REM sleep behaviour disorder.
    Stefani A; Iranzo A; Holzknecht E; Perra D; Bongianni M; Gaig C; Heim B; Serradell M; Sacchetto L; Garrido A; Capaldi S; Sánchez-Gómez A; Cecchini MP; Mariotto S; Ferrari S; Fiorini M; Schmutzhard J; Cocchiara P; Vilaseca I; Brozzetti L; Monaco S; Jose Marti M; Seppi K; Tolosa E; Santamaria J; Högl B; Poewe W; Zanusso G;
    Brain; 2021 May; 144(4):1118-1126. PubMed ID: 33855335
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Nitrated alpha-synuclein in minor salivary gland biopsies in Parkinson's disease.
    Ma LY; Gao LY; Li X; Ma HZ; Feng T
    Neurosci Lett; 2019 Jun; 704():45-49. PubMed ID: 30946930
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Novel conformation-selective alpha-synuclein antibodies raised against different in vitro fibril forms show distinct patterns of Lewy pathology in Parkinson's disease.
    Covell DJ; Robinson JL; Akhtar RS; Grossman M; Weintraub D; Bucklin HM; Pitkin RM; Riddle D; Yousef A; Trojanowski JQ; Lee VM
    Neuropathol Appl Neurobiol; 2017 Dec; 43(7):604-620. PubMed ID: 28386933
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Loss of fragile X mental retardation protein precedes Lewy pathology in Parkinson's disease.
    Tan Y; Sgobio C; Arzberger T; Machleid F; Tang Q; Findeis E; Tost J; Chakroun T; Gao P; Höllerhage M; Bötzel K; Herms J; Höglinger G; Koeglsperger T
    Acta Neuropathol; 2020 Feb; 139(2):319-345. PubMed ID: 31768670
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Alpha-Synuclein in the Gastrointestinal Tract as a Potential Biomarker for Early Detection of Parkinson's Disease.
    Fricova D; Harsanyiova J; Kralova Trancikova A
    Int J Mol Sci; 2020 Nov; 21(22):. PubMed ID: 33212934
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Value of in vivo α-synuclein deposits in Parkinson's disease: A systematic review and meta-analysis.
    Tsukita K; Sakamaki-Tsukita H; Tanaka K; Suenaga T; Takahashi R
    Mov Disord; 2019 Oct; 34(10):1452-1463. PubMed ID: 31322768
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Inoculation of α-synuclein preformed fibrils into the mouse gastrointestinal tract induces Lewy body-like aggregates in the brainstem via the vagus nerve.
    Uemura N; Yagi H; Uemura MT; Hatanaka Y; Yamakado H; Takahashi R
    Mol Neurodegener; 2018 May; 13(1):21. PubMed ID: 29751824
    [TBL] [Abstract][Full Text] [Related]  

  • 11. IL-1β/IL-1R1 signaling is involved in the propagation of α-synuclein pathology of the gastrointestinal tract to the brain.
    Muhammad B; Li H; Gu Y; Xue S; Gao Y; Xu Z; Fang X; Ding H; Wu F; Geng D; Niu H
    J Neurochem; 2023 Sep; 166(5):830-846. PubMed ID: 37434423
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Relationship between Substantia Nigra Neuromelanin Imaging and Dual Alpha-Synuclein Labeling of Labial Minor in Salivary Glands in Isolated Rapid Eye Movement Sleep Behavior Disorder and Parkinson's Disease.
    Mangone G; Houot M; Gaurav R; Boluda S; Pyatigorskaya N; Chalancon A; Seilhean D; Prigent A; Lehéricy S; Arnulf I; Corvol JC; Vidailhet M; Duyckaerts C; Degos B
    Genes (Basel); 2022 Sep; 13(10):. PubMed ID: 36292600
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Alpha-synuclein in peripheral tissues and body fluids as a biomarker for Parkinson's disease - a systematic review.
    Malek N; Swallow D; Grosset KA; Anichtchik O; Spillantini M; Grosset DG
    Acta Neurol Scand; 2014 Aug; 130(2):59-72. PubMed ID: 24702516
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Alpha-synuclein in skin as a high-quality biomarker for Parkinson's disease.
    Peng H; Chen S; Wu S; Shi X; Ma J; Yang H; Li X
    J Neurol Sci; 2023 Aug; 451():120730. PubMed ID: 37454572
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Methods for detecting toxic α-synuclein species as a biomarker for Parkinson's disease.
    O'Hara DM; Kalia SK; Kalia LV
    Crit Rev Clin Lab Sci; 2020 Aug; 57(5):291-307. PubMed ID: 32116096
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Gastrointestinal Biopsies for the Diagnosis of Alpha-Synuclein Pathology in Parkinson's Disease.
    Cersosimo MG
    Gastroenterol Res Pract; 2015; 2015():476041. PubMed ID: 26078752
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Lewy pathological study on α-synuclein in gastrointestinal tissues of prodromal Parkinson's disease.
    Lu QB; Zhu ZF; Zhang HP; Luo WF
    Eur Rev Med Pharmacol Sci; 2017 Apr; 21(7):1514-1521. PubMed ID: 28429355
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Expression of α-synuclein is regulated in a neuronal cell type-dependent manner.
    Taguchi K; Watanabe Y; Tsujimura A; Tanaka M
    Anat Sci Int; 2019 Jan; 94(1):11-22. PubMed ID: 30362073
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Alpha-synuclein redistributes to neuromelanin lipid in the substantia nigra early in Parkinson's disease.
    Halliday GM; Ophof A; Broe M; Jensen PH; Kettle E; Fedorow H; Cartwright MI; Griffiths FM; Shepherd CE; Double KL
    Brain; 2005 Nov; 128(Pt 11):2654-64. PubMed ID: 16000336
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Where and how alpha-synuclein pathology spreads in Parkinson's disease.
    Wakabayashi K
    Neuropathology; 2020 Oct; 40(5):415-425. PubMed ID: 32750743
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 18.